T-CURX
Last verified 2026-04-30. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $18.4Mattributed |
|---|---|
| Latest round | series-a, $18.5M, 2025-12-01attributed |
| Founded | 2017 |
| Headquarters | Würzburg, Germany |
| Industry | bio |
| Stage | series-a |
| Website | t-curx.com |
Biotech company developing non-viral CAR-T cell therapies for haematological cancers and solid tumours
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-12-01 | series-a | $18.5M | undisclosed |
Detected tech stack
Nginx, Craft CMS, Yii, jquery 3.6.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $18.5M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $18.4M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | t-curx.com, read 2026-04-30 |
| Description | self-reported | t-curx.com, read 2026-04-30 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.